Log in
Enquire now
‌

US Patent 10080796 Universal virus-like particle (VLP) influenza vaccines

Patent 10080796 was granted and assigned to Technovax, Inc. on September, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Technovax, Inc.
Technovax, Inc.
Current Assignee
Technovax, Inc.
Technovax, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10080796
Date of Patent
September 25, 2018
Patent Application Number
15148699
Date Filed
May 6, 2016
Patent Citations Received
‌
US Patent 10695418 Universal virus-like particle (VLP) influenza vaccines
‌
US Patent 11529410 Universal virus-like particle (VLP) influenza vaccines
Patent Primary Examiner
‌
Michelle S Horning
Patent abstract

Described herein are influenza virus-like particles (VLPs) that display on truncated, re-engineered or remodeled HA molecules on their surface. Also described are methods of making and using these VLPs.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10080796 Universal virus-like particle (VLP) influenza vaccines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us